Home » PREMARKET MOVERS: NEUROCRINE DIVES
PREMARKET MOVERS: NEUROCRINE DIVES
May 16, 2006
Shares of Neurocrine Biosciences Inc. took a premarket nosedive Tuesday after the Food and Drug Administration refused to approve the highest dose of the biotech company's insomnia drug candidate.
KEYWORDS Daily International Pharma Alert